What Elevance Health's Quarter ended Sep 30, 2026 10-Q says: 5 signals
Elevance Health filed its latest 10-Q with the SEC on Oct 21, 2026. It discusses AI investment, compliance burden and customer churn.
Public (ELV)Insuranceelevancehealth.comLinkedIn
Get Elevance Health's live signals in Claude or ChatGPT, or by API
What changed at Elevance Health this week? Use Autobound signals for elevancehealth.com.- Filed
- Oct 21, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 14
Source: Autobound Signal API · 54 signals tracked for Elevance Health · updated
10-Q · latest 10
What Elevance Health's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 5 signals
In Q1 2026, Elevance Health initiated the 2026-2027 Operating Model Transformation Program to enhance the use of advanced technologies, including artificial intelligence, across the enterprise and modernize IT platforms.
artificial intelligence
Elevance Health experienced a 1.1% decline in medical membership, dropping 487 thousand members to 44,882 thousand, driven by Medicaid attrition and decreases in Medicare Advantage and Commercial Risk-Based businesses.
-1.1%
decline in total medical membership from September 30, 2025 to September 30, 2026
The company expanded its Public Exchange operations into Washington through its Wellpoint brand in 2026, following 2025 expansions into Florida, Maryland, and Texas.
Elevance Health initiates targeted workforce reductions under ongoing Transformation Program
Elevance Health is executing targeted workforce reductions and role realignments under its 2026-2027 Operating Model Transformation Program to reduce organizational layers.
Consolidated Appropriations Act of 2026 imposes PBM rebate pass-through and reporting mandates
Enacted in February 2026, the legislation requires PBMs to remit all rebates and remuneration to commercial plan sponsors within 30 months and bans price-based remuneration in Medicare Part D by 2028.
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 5 signals
Elevance Health Q2 2026 net income falls 16.1% as benefit expense ratio rises 80 bps
Shareholders' net income decreased 16.1% to $1,463 million in Q2 2026, with the benefit expense ratio rising 80 basis points to 89.7% driven by elevated medical cost trends and morbidity.
$1.5B
Shareholders' net income for the three months ended June 30, 2026
-16.1%
decrease in shareholders' net income for the three months ended June 30, 2026 compared to prior year
In Q1 2026, management initiated the multi-year Transformation Program to streamline decision-making, modernize IT platforms, and enhance the use of advanced technologies including artificial intelligence.
artificial intelligence
Elevance Health Expanded Wellpoint Public Exchange Operations into Washington in 2026
In 2026, Elevance Health expanded Public Exchange operations into Washington through its Wellpoint brand, following 2025 expansions into Florida, Maryland, and Texas.
As part of its ongoing Transformation Program initiated in Q1 2026, the company is carrying out targeted workforce reductions and role realignments alongside IT platform modernizations.
Consolidated Appropriations Act of 2026 mandates extensive PBM reporting and rebate delinking
Enacted in February 2026, the legislation mandates pharmacy benefit managers to remit all rebates to commercial plan sponsors and provide detailed commercial claims reporting within 30 months, alongside delinking Part D compensation by 2028.
Earlier 10-Q filings
- 10-Q · Quarter ended Mar 31, 2026Filed · 4 signalsSEC EDGAR
Showing 10 of 14 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Elevance Health earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Full year 2026 adjusted EPS guidance raised to at least $29Management raised full-year 2026 adjusted diluted EPS guidance to at least $29 from prior expectations, driven by outperformance across operating segments. Additionally, the company lifted its full-year operating cash flow forecast to at least $6.5 billion. The baseline EPS for 2026 was also boosted by $0.75 to at least $26.75 heading into 2027. | |
| Deploying AI analytics for payment integrity and claims reviewThe company is investing in and deploying AI-enabled analytics to detect inappropriate billing and abnormal utilization patterns in Medicaid and ABA therapy. This technology allows payment integrity teams to investigate and address billing anomalies earlier. Clinical oversight and automated review workflows are being scaled across behavioral health networks. | |
| Operating revenue rose 1% to $50.4B with lower membershipThird quarter operating revenue increased just under 1% year-over-year to $50.4 billion, driven by higher premium yields, CarelonRx product revenue, and service fees. Benefit expense ratio improved 70 basis points to 90.6%, though adjusted operating expense ratio expanded 90 basis points to 11.3% due to targeted investments. Medical membership closed at approximately 44.9 million members. | |
| CarelonRx operating gain up 10.8% with 5.3% marginCarelonRx posted an operating gain increase of 10.8% with an operating margin of 5.3% for the third quarter. Growth was driven by solid underlying PBM execution, dispensing asset performance, and specialty pharmacy expansion. Integrated medical and pharmacy plan members showed savings up to $100 per member per month. | |
| Elevate cost platform identified over $300M in savingsElevance is rolling out and investing in its proprietary Elevate medical cost management platform across the enterprise. The platform has already surfaced more than $300 million in anticipated medical cost savings by spotting cost drivers earlier. Further investments in digital tools, care management, and patient advocacy platforms aim to improve operating efficiency. | |
| Individual ACA enrollment projected to exceed 1.2M membersIndividual ACA enrollment closed the third quarter at approximately 1.3 million members, surpassing internal projections of 1.2 million. Improved effectuation rates and lower-than-anticipated lapses drove the company to raise its year-end enrollment target to at least 1.2 million members. The expansion is heavily supported by transitions toward affordable bronze plan options. |
Signal API · MCP
Track Elevance Health with the Signal API
One POST /v1/companies/enrich call with elevancehealth.com returns Elevance Health 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"elevancehealth.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Elevance Health 10-Q
When did Elevance Health file its latest 10-Q?
What did Elevance Health disclose in its latest 10-Q?
What did Elevance Health say on its recent earnings calls?
Where can I read Elevance Health's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .